Delaware · Telemedicine
Specialized Psychiatric Care in Delaware
Verigrate Health provides physician-led psychiatric consultation by telemedicine to appropriate patients who are physically located in Delaware at the time of care. Christian S. Monsalve, M.D., personally evaluates diagnostic uncertainty, complex psychopharmacology, difficult medication histories, and questions about whether treatment should be continued, revised, simplified, or carefully tapered.
The work is deliberately consultative: records, prior responses, adverse effects, withdrawal experiences, and the patient’s goals are considered together before recommendations are made. Medication reduction is considered when clinically appropriate and is never presumed to be the goal of care.
Scope of Consultation
Clinical Questions That Benefit from a Longer View
Diagnostic clarification when symptoms, earlier diagnoses, medication effects, and treatment response no longer fit a simple account.
Individualized planning when antidepressant, benzodiazepine, sleep, stimulant, or other psychiatric medication changes require careful sequencing.
Focused review of dependence, tolerance, prior withdrawal, co-prescribed medications, and the risks of both reducing and continuing treatment.
Reassessment of indication, cumulative burden, interactions, adverse effects, and whether a simpler regimen could improve care.
Psychiatric decision-making considered alongside sleep, metabolic health, physical health, and other clinically relevant factors.
Physician consultation for alcohol-related psychiatric complexity, medication options, treatment history, and appropriate level-of-care questions.
Medication Stewardship
Psychiatric Medication Tapering in Delaware
A taper is one possible outcome of a comprehensive psychiatric review, not its assumed destination. Consultation examines the original reason for treatment, benefit over time, adverse effects, prior dose changes, withdrawal sensitivity, overlapping symptoms, and the patient’s priorities. When reduction is appropriate, recommendations address sequence, pace, monitoring, and the reasons for preserving medications that remain useful.
Review may include SSRIs and SNRIs such as escitalopram (Lexapro), sertraline (Zoloft), fluoxetine (Prozac), venlafaxine (Effexor XR), and duloxetine (Cymbalta), as well as bupropion, mirtazapine, or tricyclic antidepressants. The clinical question is not simply how to lower a dose, but whether change is indicated and how withdrawal, recurrence, and current symptoms can be distinguished.
Alprazolam (Xanax), clonazepam (Klonopin), lorazepam (Ativan), diazepam (Valium), and related medicines are reviewed in relation to duration, dependence, prior withdrawal, concurrent prescriptions, medical risk, and the purpose they continue to serve. If tapering is appropriate, the pace is individualized rather than imposed.
Sleep medications and hypnotics
Sleep-focused review may include zolpidem (Ambien), eszopiclone (Lunesta), zaleplon (Sonata), orexin receptor antagonists, sedating antidepressants, and other hypnotics. Recommendations account for insomnia itself, daytime effects, rebound symptoms, and the broader treatment plan.
Antipsychotics, mood stabilizers, and ADHD medications
Antipsychotics, lithium and other mood stabilizers, stimulant and non-stimulant ADHD treatments, anxiolytics, adjunctive medicines, and medications used in substance-related care may also be assessed. Complex regimens are reviewed as a whole so that timing, interactions, and diagnostic assumptions are not separated from one another.
Clinical Judgment Before Reduction
A medication change is not a default protocol. Recommendations weigh current benefit, adverse effects, withdrawal sensitivity, diagnostic clarity, medical context, available support, and the risks of both changing and continuing treatment.
How Care Works
Physician-Led Psychiatric Consultation Across Delaware
Appropriate patients may receive specialized psychiatric consultation by secure telemedicine while physically located in Delaware at the time of the appointment. The consultation may address unresolved diagnosis, a difficult medication history, complex psychopharmacology, deprescribing, or a proposed taper. Care is non-emergency and subject to clinical fit, practice capacity, and the patient’s location at the time of care.
Practice Structure
Common Questions
Is Verigrate psychiatric consultation available by telemedicine in Delaware?
Yes. Verigrate provides physician-led psychiatric consultation by secure telemedicine to appropriate patients who are physically located in Delaware at the time of care. The practice does not represent a physical Delaware office and does not provide emergency or walk-in services.
What happens during a complex medication review?
The review reconstructs why each medication was started, what changed over time, which benefits remain, what adverse effects or interactions matter, and whether prior dose changes produced withdrawal or recurrence. Recommendations follow from the complete history rather than one prescription in isolation.
Can psychiatric medication tapering be considered?
Yes. Antidepressant, benzodiazepine, hypnotic, stimulant, antipsychotic, mood-stabilizer, or other psychiatric medication tapering may be considered when there is a sound clinical reason to reconsider treatment. A recommendation to reduce is not automatic.
Is stopping medication always the goal?
No. Consultation may support continuing the present regimen, clarifying the diagnosis, adjusting one part of treatment, simplifying medication burden, postponing a taper, or developing a gradual reduction plan. Clinical appropriateness comes before discontinuation.
How does an initial Delaware consultation begin?
It begins with an unhurried review of current concerns, prior diagnoses, treatment response, medication sequence, withdrawal experiences, relevant medical factors, available records, and the questions the patient hopes to answer. Dr. Monsalve then discusses individualized recommendations and whether ongoing care is appropriate.